News updates from the JAAD family of journals

• ●

  Congratulations to JAAD

• ●

  Congratulations to Dr. Grant-Kels on Clarence S. Livingood, MD Award and Lectureship

• ●

  Case reports prompt CDC investigation of possible treatment-resistant dermatophytosis

• ●

  Congratulations and Welcome to Dr. Julia Riley, JAAD Case Reports New Skin of Color Special Editor

• ●

  JAAD Skin of Color Image Collection and Atlas

• ●

  Digital Health in Dermatology

• ●

  COVID-19 and the Skin

Congratulations to the Journal of the American Academy of Dermatology!

For the fourth year in a row JAAD(opens in new tab/window) holds the #1 Impact Factor in the Dermatology category with a 2022 IF of 13.8!

JAAD Deputy Editor Jane Grant-Kels, MD, FAAD, professor of dermatology, pathology, and pediatrics, and director of the Cutaneous Oncology Center and Melanoma Program at the University of Connecticut, delivered the Clarence S. Livingood, MD Award and Lectureship during the Plenary Session at the 2023 AAD Annual Meeting in New Orleans on March 19.

Speaking on the topic “Ethical Dilemmas Hiding in Plain Site(opens in new tab/window)”, Dr. Grant-Kels explored the importance of ethics and the nuanced boundaries of ethical behavior in the practice of dermatology.

To read more about the substance of this lecture, and other news from the 2023 AAD Annual Meeting, visit the DermWorld Meeting News Central website(opens in new tab/window).

Responding to JAAD Case Reports articles indicating a growing problem, the United States Centers for Disease Control and Prevention (CDC) is investigating whether a pattern of treatment-resistant dermatophytosis is emerging.

The CDC asks dermatologists who see patients with tinea infections to complete its survey so it can assess the extent of this problem.

Gu, David et al reported what they believed to be the first U.S. case of treatment-resistant dermatophytosis in a 2020 JAAD Case Reports article(opens in new tab/window). A response in 2022(opens in new tab/window) suggested a second case had been identified. The literature indicates that treatment resistance has been seen in India and possibly elsewhere.

Dr. Julia Riley is an Assistant Professor of Dermatology at Feinberg School of Medicine. Dr. Riley completed her residency at Northwestern in 2020 before joining the faculty. At Northwestern, she serves as the Assistant Director of the Center for Ethnic Skin & Hair and the Director of the HS Clinic. She also serves as the Dermatology Clerkship Director and the Co-Chair of the Department of Dermatology’s Diversity and Inclusion Committee. Her clinical interests include Skin of Color, spanning from pigmentary disorders to hair disorders, as well as Hidradenitis Suppurativa. Her research interests include disparities in Hidradenitis Suppurativa as well as education of residents, medical students and other health care providers on the diagnosis and management of dermatologic conditions in patients of color. Additionally, Dr. Riley is pursuing a master’s degree in health services and outcomes research.